VVOS | Vivos Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.44 - 3.79
52 Week Range	1.9100 - 18.85
Beta	3.96
Implied Volatility	271.22%
IV Rank	79.23%
Day's Volume	89,775
Average Volume	1,416,919
Shares Outstanding	4,835,300
Market Cap	17,600,492
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2020-12-11

Valuation
Profitability
Growth
Health
P/E Ratio	-0.73
Forward P/E Ratio	N/A
EPS	-4.99
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	114
Country	USA
Website	VVOS

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.

VVOS's peers: AEMD, BBLG, BSGM, BVS, CODX, ECOR, HSDT, IINN, MYO, NAOV, NSPR, NURO, QTRX, RPID, TIVC, BJDX, TLIS, NUWE, HSCS

*Chart delayed

Analyzing fundamentals for VVOS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see VVOS Fundamentals page.

Watching at VVOS technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on VVOS Technicals page.